Beiträge

Evidence-Based Medicine in Oncology: Commercial Versus Patient Benefit

Position paper: new insights into the immunobiology and dynamics of tumor-host interactions require adaptations of clinical studies

Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

Breaking Therapy Resistance: An Update on Oncolytic Newcastle Disease Virus for Improvements of Cancer Therapy

Immune Phenotype Correlates With Survival in Patients With GBM Treated With Standard Temozolomide-based Therapy and Immunotherapy

Immunotherapy in atypical teratoid-rhabdoid tumors: Data from a survey of the HGG-Immuno Group

Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade glioma

Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines

Irradiation of necrotic cancer cells, employed for pulsing dendritic cells (DCs), potentiates DC vaccine-induced antitumor immunity against high-grade glioma

Tumour Relapse Prediction Using Multiparametric MR Data Recorded during Follow-Up of GBM Patients